Beam Therapeutics Inc (BEAM) — Capital Reinvestment Ratio
Beam Therapeutics Inc (BEAM) has a Capital Reinvestment Ratio of 0.03x as of December 2023, meaning it reinvests 0% of its operating cash flow ($135.07 Million) in capital expenditures ($3.59 Million). See BEAM net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Beam Therapeutics Inc Capital Reinvestment Ratio (2022–2022)
This chart tracks Beam Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check how aggressively does Beam Therapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Beam Therapeutics Inc (2022–2022)
Year-by-year Capital Reinvestment Ratio for Beam Therapeutics Inc from 2022 to 2022. For live market cap and broader valuation context, see market cap of Beam Therapeutics Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 2.17x | $22.53 Million | $48.95 Million | — |